Short courses of ofloxacin for the treatment of enteric fever

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 91, Issue 3, 1997, Pages 347-349

  Chinh, Nguyen Tran ^a   Solomon, Tom ^a,b   Thong, Mai Xuan ^a   Ly, Nguyen Thi ^a   Hoa, Nguyen Thi Tuyet ^a   Wain, John ^a,b   Diep, To Song ^a   Smith, Michael D ^a,b   Day, Nicholas P J ^a,b   Phi, Le Thi ^a   Parry, Christopher ^a,b   White, Nicholas J ^a,b  

^a CHO QUAN HOSPITAL   (Viet Nam)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Enteric fever; Ofloxacin; Salmonella paratyphi; Salmonella typhi; Typhoid

Indexed keywords

ANTIBIOTIC AGENT; NALIDIXIC ACID; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL; SALMONELLA PARATYPHI; SALMONELLA TYPHI; TREATMENT FAILURE; TROPICS; TYPHOID FEVER;

SALMONELLA PARATYPHI; SALMONELLA TYPHI;

EID: 8244225817     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(97)90102-4     Document Type: Article

References (19)

1. Achayara, G., Butler, T., Ho, M., Sharma, P. R., Tiwari, M., Adhikari, R. K., Khagda, J. B., Pokhrel, B. & Pathak, U. N. (1995). Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol. American Journal of Tropical Medicine and Hygiene, 52, 162-165.
2. Bethell, D. B., Hien, T. T., Phi, L. T., Day, N. P. J., Vinh, H., Dung, M. N., Len, N. V., Chuong, L. V. & White, N. J. (1996).The effects on growth of single short courses of fluoroquinolones. Archives of Diseases in Childhood, 74, 44-46.
3. Butler, T., Linh, N. N., Arnold, K. & Pollack, M. (1973). Chloramphenicol-resistant typhoid fever in Viet Nam associated with R-factor. Lancet, ii, 983-985.
4. Butler, T., Rumans, L. & Arnold, K. (1982). Response of typhoid fever caused by chloramphenicol-resistant strains of Salmonella typhi to treatment with trimethoprim-sulphamethoxazole. Reviews of Infectious Diseases, 4, 551-561.
5. Edelman, R. & Levine, M. M. (1986). Summary of an international workshop on typhoid fever. Reviews of Infectious Diseases, 8, 329-349.
6. Hien, T. T., Duong, N. M., Ha, H. D., Hoa, N. T. T., Diep, T. S., Phi, L. T. & Arnold, K. (1994). A randomized comparative study of fleroxacin and ceftriaxone in enteric fever. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 464-465.
7. Hien, T. T., Bethell, D. B., Hoa, N. T. T., Wain, J., Diep, T. S., Phi, L. T., Cuong, B. M., Duong, N. M., Thanh, P. T., Walsh, A. L., Day, N. P. J. & White, N. J. (1995). Short course ofloxacin treatment of multi-drug resistant typhoid. Clinical Infectious Diseases, 20, 917-923.
8. Hoa, N.T.T., Phi, L. E., Hien, T. T., Smith, M. D. & White, N. J. (1992). Antibiotic resistance in Salmonella typhi and 5. paratyphi A from Viet Nam. Abstracts: XIIIh International Congress for Tropical Medicine and Malaria; Pattaya, Thailand, abstract no. WeP3-2, p. 193.
9. Islam, A., Butler, T., Nath, S. K., Alam, N. H., Stoeckel, K., Houser, H. B. & Smith, A. L. (1988). Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol. Journal of Infectious Diseases, 158, 742-747.
10. Jesudason, M. V. & John, T. J. (1990). Multiresistant Salmonella typhi in India. Lancet, 336, 252.
11. Lewin, C. S., Nandivada, L. S. & Aymes, S. G. B. (1991). Multi-resistant Salmonella and fluoroquinolones. Journal of Antimicrobial Chemotherapy, 227, 147-149.
12. Meskin, S., Jacob, M. S., Macaden, R., Keystone, J. S., Kozarsky, P. E., Ramachadran, A. N. & Metchock, B. (1992). Short-course treatment of typhoid fever with ciprofloxacin in south India. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 446-447.
13. Panicker, C. K. J. & Vimala, K. N. (1972). Transferable chloramphenicol resistance in Salmonella typhi. Nature, 239, 109-110.
14. Ramirez, C. A. J., Bran, L., Mejia, C. R. & Garcia, J. F. (1985). Open, prospective study of the clinical efficacy of ciprofloxacin. Antimicrobial Agents and Chemotherapy, 28, 128-132.
15. Rowe, B., Ward, L. R. & Threlfall, E. J. (1995). Ciprofloxacin-resistant. Salmonella typhi in the UK. Lancet, 346, 1302.
16. Smith, M. D., Duong, N. M., Hoa, N. T. T., Wain, J., Ha, H. D., Diep, T. S., Day, N. P. J., Hien, T. T. & White, N. J. (1994). Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever. Antimicrobial Agents and Chemotherapy, 38, 1716-1720.
17. Vinh, H., Wain, J., Hanh, V. T. N., Nga, C. N., Chinh, M. T., Bethell, D., Hoa, N. T. T., Diep, T. S., Dung, N. M. & White, N. J. (1996). Two or three days of ofloxacin for uncomplicated multi-drug resistant typhoid fever in children. Animicrobial Agents and Chemotherapy, 40, 958-961.
18. Wallace, M. & Yousif, A. A. (1990). Spread of multiresistant Salmonella typhi. Lancet, 336, 1065-1066.
19. Wang, F., Gu, X. J., Zhang, M. F. & Tai, Y. T. (1989). Treatment of typhoid fever with ofloxacin. Journal of Antimicrobial Chemotherapy, 23, 785-788.